ADMA ADMA BIOLOGICS INC

Ownership history in Man Group plc  ·  7 quarters on record

This page tracks every 13F SEC filing in which Man Group plc reported a position in ADMA BIOLOGICS INC (ADMA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.03% (2024 Q4)
Avg. % of fund
0.01%
First filed
2022 Q1
Last filed
2025 Q3
Quarters held
7
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 24,319 -104,099 -81.1% 0.00% $357K $14.66
2025 Q2 REDUCED 128,418 -29,727 -18.8% 0.00% $2.3M $18.21
2025 Q1 REDUCED 158,145 -587,155 -78.8% 0.01% $3.1M $19.84
2024 Q4 ADDED 745,300 +561,507 +305.5% 0.03% $12.8M $17.15
2024 Q3 ADDED 183,793 +158,195 +618.0% 0.01% $3.7M $19.99
2024 Q1 REDUCED 25,598 -66,119 -72.1% 0.00% $169K $6.60
2022 Q1 INITIATED 91,717 0.00% $168K $1.83
% of Fund (quarterly)    ADMA price (monthly, adj. close)
← Back to Man Group plc Holdings